Adherium, a digital health company that improves medication adherence and patient outcomes, has appointed Timothy A. Marcotte as its new CFO.
Marcotte will join the Company’s leadership team and be based out of the Company’s US headquarters in San Mateo, California.
Arik Anderson, CEO of Adherium, said: “We are thrilled to have Tim join the Adherium team. His extensive experience in overseeing product rollouts into new markets will be invaluable and contribute significantly to our future strategy in the US. We continue to build out our presence in the US and a recent 510(k) clearance and new product releases signify our growing commercial activities in the region.”
Marcotte has more than 35 years of experience working at public and private medical device companies holding various C-level positions, including CEO, CFO and COO.
Prior to joining Adherium, he worked at several medical device companies, including Zonare Medical Systems, VNUS Medical Technologies and Repeater Technologies.
Marcotte’s experience includes overseeing multiple initial public offerings through his prior CFO roles. He earned an MBA from the University of Michigan.
Former CFO Rob Turnbull transitions to a new role of VP of Finance and Business Services. In this role Turnbull will assume a number of additional operational responsibilities across Adherium.
Adherium recently hit a number of new commercial milestones with the thousandth Smartinhaler sold, FDA clearance of its next generation Smartinhaler for AstraZeneca’s Symbicort aerosol inhaler and also the launch of Adherium’s next generation device for AstraZeneca’s Symbicort Turbuhaler.
